The VR Foundation Board of Directors today announced the resignation of Igor Korobko, PhD, DSci, who has served as Chief Scientific Director of the organization since it's inception. Dr. Korobko had informed the Board he intended to resign and focus on his academic career at the end of 2016. And he felt that moving up his resignation date to after the AAD Congress in early March of 2017 would allow VRF to complete the ongoing projects and to facilitate VRF’s continuing focus on its broader mission.
While the Board has the utmost regard for Dr. Korobko’s skills, professionalism and integrity, it accepted his resignation. The Board expressed its gratitude to Dr. Korobko for his unparalleled service as the Chief Scientific Director.
Among the many accomplishments of VRF under his scientific leadership was the development, in 2011, of the first comprehensive Vitiligo Electronic Health Record and Vitiligo Biobank Network, the translation of science into clinical interventions and drug repurposing, and regular Quarterly Reports. “We are grateful for Dr. Korobko’s distinguished tenure and numerous contributions,” the Board said. “Our non-profit organization has been very fortunate to have Dr. Korobko as Chief Scientific Director for so many years, and we wish him well.”
Dr. Korobko will continue his academic research as a Deputy Director and Head of the lab at the Institute of Gene Biology in Moscow, Russia. The Board will appoint a successor to the Chief Scientific Director in the near future.
I support the petition to designate June 25 as Vitiligo World Day and save millions of people worldwide from social isolation and persecution.
What is coming?
High-level Meeting on the Asian and Pacific Decade of People With Disabilities
The UN's Economic and Social Commission for Asia and the Pacific (ESCAP), in cooperation with the China Disabled Persons’ Federation (CDPF), is organizing the High-lev...27 November 2017 09:00, Beijing, China
XXIV Master Class in Ha Noi, Vietnam
will be held alongside 3rd Indo China Dermatology Conference and the Annual Scientific Meeting Of Dermatology and Venereology of the VSDV. Details01 December 2017 09:00, Melia Hotel, 44 Ly Thuong Kiet, Ha...
What's better: laser or phototherapy?
In a recent controlled study researchers assessed effect and safety of different laser and phototherapy treatments, such as excimer laser/light, narrowband UVB, UVA an...
Are there any famous people with vitiligo?
Many celebrities have dealt with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career. Here are a few courageous ...
Can Scenesse be used for vitiligo treatment?
The drug Scenesse from Clinuvel has been tested in clinical trials in relation vitiligo. Profs. Henry Lim, Mark Lebwohl and coauthors reported (PubMed) results of mult...